The new grant will support efforts by Johns Hopkins physician-scientists to participate in a novel multidisciplinary clinical trial for this cancer, called ADAPT-BLADDER for its ability to accommodate changes during the trial that optimize and accelerate tests of promising treatments.
See full article link: https://www.mlo-online.com/disease/cancer/article/21087449/johns-hopkins-research-focused-on-early-stage-bladder-cancer-wins-32-million-federal-grant
Comments